HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 DegradationSUMMARY
Background & Aims: The contribution of abnormal metabolic targets to hepatocellular carcinoma (HCC) progression and the associated regulatory mechanisms are attractive research areas. High-density lipoprotein binding protein (HDLBP) is an important transporter that protects cells from excessive...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2023-01-01
|
| Serija: | Cellular and Molecular Gastroenterology and Hepatology |
| Teme: | |
| Online pristup: | http://www.sciencedirect.com/science/article/pii/S2352345X22002168 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
